: Many herpes viruses encode proteins that disrupt the MHC class I pathway of antigen processing; these genes offer insights into basic immunological and cell biological processes, and provide new tools for immunological investigation and potentially therapeutics. Murine cytomegalovirus (MCMV) offers a unique opportunity to understand how these genes function and their impact on the immune system in the host with which they have co-evolved for tens of millions of years. Two MCMV genes (m6 and ml 52) have been shown to interfere with antigen processing. Evidence is presented that a third gene, m4, also interferes with antigen presentation. m4 is unique amongst viral immune evasion genes in that it does not alter the trafficking pattern of class I molecules. Its product, m4gp34, is primarily found in the ER, where it interacts extensively with class I. A small portion of m4gp34 forms a different, detergent stable complex with class I and travels with it to the cell surface where they remain tightly associated. The goal of this project is to identify the molecular mechanism whereby m4gp34 inhibits antigen presentation. Recombinant MCMV expressing ova wilt be established to enable the effect of m4gp34 on class I loaded with specific antigenic peptide to be followed. These will be used to determine, firstly, whether m4gp34 acts at the cell surface to inhibit the ability of the class 1-peptide complex to engage its receptor or co-receptor and transmit an activating signal to CTL; and secondly, whether m4gp34 in the ER interferes with the ability of Kb molecules to acquire antigenic peptide.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI050099-05
Application #
7027644
Study Section
Immunobiology Study Section (IMB)
Program Officer
Beisel, Christopher E
Project Start
2002-09-01
Project End
2007-02-28
Budget Start
2006-03-01
Budget End
2007-02-28
Support Year
5
Fiscal Year
2006
Total Cost
$258,041
Indirect Cost
Name
Oregon Health and Science University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Doom, Carmen M; Turula, Holly M; Hill, Ann B (2009) Investigation of the impact of the common animal facility contaminant murine norovirus on experimental murine cytomegalovirus infection. Virology 392:153-61
Holtappels, Rafaela; Simon, Christian O; Munks, Michael W et al. (2008) Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination. J Virol 82:5781-96
Pinto, Amelia K; Jamieson, Amanda M; Raulet, David H et al. (2007) The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40. J Virol 81:12564-71
Munks, Michael W; Pinto, Amelia K; Doom, Carmen M et al. (2007) Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J Immunol 178:7235-41
Lu, Xiuju; Kavanagh, Daniel G; Hill, Ann B (2006) Cellular and molecular requirements for association of the murine cytomegalovirus protein m4/gp34 with major histocompatibility complex class I molecules. J Virol 80:6048-55
Pinto, Amelia K; Munks, Michael W; Koszinowski, Ulrich H et al. (2006) Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J Immunol 177:3225-34
Munks, Michael W; Gold, Marielle C; Zajac, Allison L et al. (2006) Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus. J Immunol 176:3760-6
Munks, Michael W; Cho, Kathy S; Pinto, Amelia K et al. (2006) Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol 177:450-8